Lori Goldstein, MD

Request an Appointment Online - Click Here

New patients can request an appointment online or call
215-728-3001

Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111

Video: Lori Goldstein, MD

Lori J Goldstein, MD

Philadelphia Magazine
Top Doctors 2012
Medical Oncology

Call the Breast Evaluation Center
at 215-728-3001.
You must have a diagnosed case of breast cancer but you must not have started treatment.
If you have started treatment, but wish to get a second opinion,
call 215-728-2600.

Dr. Goldstein's
Patient Stories

Linda Angello - Breast Cancer Patient Stories
Ellen Anthonisen - Breast Cancer Patient Stories
Dina Gillis - Breast Cancer Patient Stories
Linda Gottlieb - Breast Cancer Patient Stories
Kim Hagerich - Plastic and Reconstructive Surgery Patient Stories, Breast Cancer Patient Stories
Carlette Knox - Breast Cancer Patient Stories, Risk Assessment Program Patient Stories
Robin Luber - Breast Cancer Patient Stories, Clinical-Trials Patient Stories
Shari Lynn - Breast Cancer Patient Stories
Laura Marblestone - Breast Cancer Patient Stories
Marion Utain - Breast Cancer Patient Stories
Margaret Zuccotti - Inflammatory Breast Cancer Patient Stories

New Small Molecule Inhibitor Could be a Safe and First-Line Treatment for Metastatic Breast Cancer
(Dec 7, 2012)

Dr. Lori Goldstein talks about living with breast cancer on National Public Radio (NPR), March 22, 2007.

Medical Oncology

Director,
The Naomi and Phil Lippincott Breast Evaluation Center
Co-Leader,
Breast Cancer Clinical Research Program

Clinical Expertise:

Breast Cancer; Novel Therapeutic; Translational Research

Certifications:

American Board of Internal Medicine, Internal Medicine, Medical Oncology

As a medical oncologist specializing in breast cancer, I believe in providing women the most tailored, state-of-the-art treatment options. That is why I created the (BEC) when I joined the staff at Fox Chase Cancer Center in 1990.

As the director of the BEC, I work with a team of breast cancer experts, including medical oncologists, surgical oncologists, radiation oncologists, radiologists, pathologists and social workers. Together, we develop a comprehensive treatment plan for patients with early stage breast cancer.

By providing patients with useful information about their treatment options, we are empowering them with the knowledge to make informed decisions about their care. I believe this is very important for women who have been diagnosed with breast cancer, as they can be overwhelmed with the amount of information available today.

In addition to my clinical expertise in breast cancer, I am dedicated to breast cancer research. At Fox Chase, I was the first leader of the Breast Cancer Research Program (now the )Women's Cancer Research Program). In this program, I work with investigators from basic, clinical, and population science who collaborate in their research of breast cancer prevention, what causes tumors to develop, detection and treatment.

I have devoted my career to translational research, which turns basic research into therapeutic treatment for breast cancer patients. At the same time, my interest in investigational research is to reduce the incidence of breast cancer and improve outcomes.

I am committed to generating a national agenda for breast cancer research and care. Because of this interest along with my experience in research, Fox Chase Cancer Center has chosen me to represent the institution as the Principal Investigator for the Eastern Cooperative Oncology Group (ECOG). ECOG conducts clinical trials in all types of adult cancers and is one of the largest clinical cancer research organizations in the United States. ECOG has appointed me as an active member of their Breast CORE committee and Principal Investigator for the Data Safety and Monitoring Committee.

In addition, I serve as a member of the Breast Cancer Guidelines Committee for the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers, including Fox Chase Cancer Center. In my time here, I have been at the start of some major programs, including my experience as the original Director of the Women’s Cancer Center and one of the establishing members of the Clinical Breast Cancer Survivors Program at FCCC. I am also on the Institutional Review Board; Data Safety and Monitoring Committee, Extramural Research Program; Steering Committee of Breast Survivorship Program; Navigation Steering Committee; and the Ambulatory Services Steering Committee.

Medical Education

State University of New York Upstate College of Medicine, Syracuse, NY, 1982

Residencies

Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pa.

Fellowships

Oncology, Division of Cancer Treatment, National Cancer Institute, Division of Cancer Biology and Diagnosis, National Cancer Institute, Washington, D.C.

Professional Societies

American Association of Cancer Research, Tellers Committee; American Society of Clinical Oncology – Program in Breast Cancer: Guest Editor; ECOG, Breast Core Committee, Leader Developmental Therapeutics Working Group NCCN, Breast Cancer Panel ECOG, Audit Committee, Breast Cancer Liaison to Developmental Therapeutics Committee People Living With Cancer; DOD COE Hormone Rresistance Grant, Co-PI; Breast Cancer Symposium, Program Committee – Co-Chair Elect 2012

Research Interests

FCCC, ECOG Principal Investigator: Lori J Goldstein, MD - Director, Breast Evaluation Center
Breast Cancer; Developmental Therapeutics; Translational Research;